Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (21)

2026

  1. Health-Related Quality of Life in Radiologically Isolated Syndrome Resembles Relapsing–Remitting Multiple Sclerosis

    Journal of Clinical Medicine, Vol. 15, Núm. 6

  2. Influence of the level of education on cognitive function in Parkinson’s disease

    Journal of Neural Transmission, Vol. 133, Núm. 4, pp. 663-681

  3. Predictive Factors and Impact of Significant Weight Loss on Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice

  4. Profile of People With Parkinson's Disease Treated With a Device-Aided Therapy in Spain. A Comparative Multicenter Observational Study

    Movement Disorders Clinical Practice, Vol. 13, Núm. 1, pp. 154-172

  5. The Parkinson's Real-World Impact Assessment (PRISM) project in the management and burden of Parkinson's disease in Spain

    Neurologia, Vol. 41, Núm. 3

2025

  1. Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease

    Clinical Parkinsonism and Related Disorders, Vol. 12

  2. Correction to: Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline (Journal of Neurology, (2025), 272, 3, (246), 10.1007/s00415-024-12808-0)

    Journal of Neurology

  3. Cortical volumetry and longitudinal cognitive changes in Parkinson’s disease: insights from the COPPADIS cohort

    Brain Imaging and Behavior, Vol. 19, Núm. 5, pp. 1048-1060

  4. Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations

    Neurologia, Vol. 40, Núm. 2, pp. 171-181

  5. Dysphagia in Parkinson´s disease. A 5-year follow-up study

    Neurological Sciences, Vol. 46, Núm. 6, pp. 2637-2653

  6. Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline

    Journal of Neurology, Vol. 272, Núm. 3

  7. Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis

    Frontiers in Immunology, Vol. 16

  8. Impact of device-aided therapies on quality of life in patients with Parkinson’s disease. A comparative multicenter observational study

    Journal of Neural Transmission

  9. New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosis

    Frontiers in Immunology, Vol. 16

  10. Parkinson’s disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial

    npj Parkinson's Disease, Vol. 11, Núm. 1

2024

  1. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966